Glanbia Plc Reports Strong Half-Year Results with Revenue Growth

Glanbia Plc has disclosed encouraging financial results for the six-month period ending July 5, 2025. The Kilkenny-based company reported a revenue growth of 6%, attributed to strong performance in its Health & Nutrition (H&N) and Dairy Nutrition (DN) divisions, despite facing significant macroeconomic challenges.

In a statement, Hugh McGuire, Chief Executive Officer of Glanbia, emphasized that the results reflect a robust first half characterized by “significant execution and progress.” He noted that volume growth, alongside earnings and margin improvements in the H&N and DN sectors, demonstrated strong customer demand. However, the anticipated decline in Performance Nutrition (PN) results was largely driven by elevated whey costs during the reporting period.

During the second quarter, Glanbia also reported positive developments, including volume and price growth for its flagship brand, Optimum Nutrition. This growth reflects a broader recovery trend within the company, as demand for nutritional products continues to rise.

Strategic Acquisitions and Financial Returns

In line with its growth strategy, Glanbia announced the acquisition of Sweetmix, a Brazilian nutritional premix and ingredients solutions business. This move is expected to enhance the company’s presence and growth prospects in the Latin American market.

The company’s financial discipline is evident, with strong operating returns and cash conversion. Glanbia increased its interim dividend by 10% and returned €62.8 million to shareholders through share buyback programs during the reported period.

Looking ahead, Glanbia has upgraded its full-year adjusted earnings per share (EPS) guidance to a range of 130 to 133 cents. This adjustment is based on increased revenue momentum in the Performance Nutrition division and improved margins within the Health & Nutrition sector.

McGuire highlighted that category trends remain positive, and the company anticipates further volume improvements across Performance Nutrition in the latter half of the year, alongside sustained growth in Health & Nutrition and Dairy Nutrition.

Overall, Glanbia’s performance in the first half of 2025 showcases its resilience in navigating challenging market conditions while seizing opportunities for growth. With strategic acquisitions and a commitment to returning value to shareholders, the company is well-positioned for continued success.